Pay in 4 interest-free payments of $5.48 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
All information provided is for educational and research purposes only , and this product must never be used in humans or animals
The drug recently showed very promising early Phase II data in MASH, a liver disease closely associated with obesity
Tirzepatide is unique because it targets two hormones that play major roles in appetite and blood sugar controlGLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide)
obesity)
The company was recently sued over its lack of GLP-1 coverage for those suffering from obesity
US$ 26.68
.png)
US$ 29.07
US$ 26.97
US$ 21.35
US$ 22.65
US$ 24.89
